SEC Form D private-offering filing

Cue Biopharma, Inc.

Name: Cue Biopharma, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2026-05-14

A new SEC Form D private-offering notice from Boston, MA, a $29,999,992 filer-stated offering target in Biotech. The source filing is one click away.

Cue Biopharma, Inc. site↗ Verified via SEC Form D

Publicly traded (NASDAQ: CUE) clinical-stage biopharmaceutical company developing engineered immuno-oncology and immunology biologics via its Immuno-STAT platform

Filed 2026-05-14Filed to raise $29,999,992First money in 2026-05-04Raised so far $29,999,992HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified cuebiopharma.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.